Literature DB >> 20553671

Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents.

Brian E Perron1, Michael G Vaughn, Matthew O Howard, Amy Bohnert, Erick Guerrero.   

Abstract

OBJECTIVE: Inhalants are a serious public health concern and a dangerous form of substance use. An important unresolved issue in the inhalant literature concerns the validity of inhalant-use diagnoses and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, distinction between inhalant abuse and inhalant dependence. To address these limitations and provide the foundation for helping build stronger diagnostic and assessment tools related to inhalant problems, this study examined the dimensionality of the criteria set and the abuse-dependence distinction using item response theory (IRT) analysis.
METHOD: This study used data from a survey of the population of Missouri Division of Youth Services' residents of the residential treatment system. The current study focused on adolescents and young adults who reported a lifetime history of inhalant use (N = 279).
RESULTS: The results from the IRT analysis showed no consistent hierarchical ordering of abuse and dependence criteria, providing strong evidence against the abuse-dependence distinction. The abuse criterion of legal problems associated with use represented the item with the highest level of inhalant severity. The dependence criterion that was related to giving up important social, occupational, or recreational activities provided the most accurate discrimination between individuals at different levels of severity.
CONCLUSIONS: Inhalant-use disorders are best represented using a dimensional versus a categorical approach. IRT analysis provides guidance for selecting criteria that can be useful for brief assessments of inhalant-use problems.

Entities:  

Mesh:

Year:  2010        PMID: 20553671      PMCID: PMC2887928          DOI: 10.15288/jsad.2010.71.607

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  32 in total

1.  Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity.

Authors:  J Brown; H R Kranzler; F K Del Boca
Journal:  Br J Addict       Date:  1992-07

2.  Controlling deaths from volatile substance abuse in under 18s: the effects of legislation.

Authors:  A Esmail; H R Anderson; J D Ramsey; J Taylor; A Pottier
Journal:  BMJ       Date:  1992-09-19

Review 3.  Abuse potential evaluation of inhalants.

Authors:  R L Balster
Journal:  Drug Alcohol Depend       Date:  1987-01       Impact factor: 4.492

4.  Inhalant abuse and the abuse of other drugs.

Authors:  S J Young; S Longstaffe; M Tenenbein
Journal:  Am J Drug Alcohol Abuse       Date:  1999-05       Impact factor: 3.829

5.  Test-retest reliability of psychoactive substance abuse and dependence diagnoses in telephone interviews using a modified Diagnostic Interview Schedule-Substance Abuse Module.

Authors:  G B Aktan; R F Calkins; K M Ribisl; A Kroliczak; R M Kasim
Journal:  Am J Drug Alcohol Abuse       Date:  1997-05       Impact factor: 3.829

Review 6.  Abuse of inhalants: a review.

Authors:  S H Dinwiddie
Journal:  Addiction       Date:  1994-08       Impact factor: 6.526

Review 7.  A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation.

Authors:  Ayman A El-Menyar; Mohammed El-Tawil; Jassim Al Suwaidi
Journal:  Eur J Emerg Med       Date:  2005-06       Impact factor: 2.799

8.  Alcohol dependence and abuse diagnoses: concurrent validity in a nationally representative sample.

Authors:  D Hasin; A Paykin
Journal:  Alcohol Clin Exp Res       Date:  1999-01       Impact factor: 3.455

Review 9.  Neural basis of inhalant abuse.

Authors:  R L Balster
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

10.  Neurologic sequelae of chronic solvent vapor abuse.

Authors:  J T Hormes; C M Filley; N L Rosenberg
Journal:  Neurology       Date:  1986-05       Impact factor: 9.910

View more
  7 in total

1.  Service use and treatment barriers among inhalant users.

Authors:  Brian E Perron; Orion Mowbray; Sarah Bier; Michael G Vaughn; Amy Krentzman; Matthew O Howard
Journal:  J Psychoactive Drugs       Date:  2011 Jan-Mar

2.  Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients.

Authors:  Deborah S Hasin; Miriam C Fenton; Cheryl Beseler; Jung Yeon Park; Melanie M Wall
Journal:  Drug Alcohol Depend       Date:  2011-10-02       Impact factor: 4.492

3.  Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition.

Authors:  Bradley T Kerridge; Tulshi D Saha; Sharon Smith; Patricia S Chou; Roger P Pickering; Boji Huang; June W Ruan; Attila J Pulay
Journal:  Addict Behav       Date:  2011-05-28       Impact factor: 3.913

Review 4.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

5.  Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV?

Authors:  Ty A Ridenour; Amanda E Halliburton; Bethany C Bray
Journal:  Psychol Addict Behav       Date:  2014-08-18

Review 6.  Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.

Authors:  Dvora Shmulewitz; Emily R Greene; Deborah Hasin
Journal:  Alcohol Clin Exp Res       Date:  2015-09-01       Impact factor: 3.455

7.  An Item Response Theory Analysis of DSM-5 Heroin Use Disorder in a Clinical Sample of Chinese Adolescents.

Authors:  Hongmei Yang; Fu Chen; Xiaoxiao Liu; Tao Xin
Journal:  Front Psychol       Date:  2019-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.